EPO Patents = 1

Forward Citations = 2

Loading Chart...

6 inventors (with patents filed for the assignee):

Graham Beaton (6 out of 13 patents)

Chandravadan R Shah (6 out of 36 patents)

Fabio C Tucci (6 out of 20 patents)

4. Satheesh Babu Ravula (6 out of 11 patents)

5. Hiep Luu (4 out of 8 patents)

6. Suk Joong Lee (2 out of 6 patents)

7. Satheesh B Ravula (0 patent)

6 patents: Sort by Forward Citations

1. 12234224 - Pyrimidine and pyridine amine compounds and usage thereof in disease treatment (2025-02-25),

2. 11866421 - Pyrimidine and pyridine amine compounds and usage thereof in disease treatment (2024-01-09),

3. 11427552 - Heterocyclic compounds useful in the treatment of disease (2022-08-30),

4. 10570103 - Heterocyclic compounds useful in the treatment of disease (2020-02-25),

5. 10526298 - Heterocyclic compounds useful in the treatment of disease (2020-01-07),

6. 10000459 - Heterocyclic compounds useful in the treatment of disease (2018-06-19),

Company Overview

Epigen Biosciences, Inc. is a biotechnology company focused on epigenetic research and drug development. Using innovative technologies, Epigen Biosciences is dedicated to discovering new therapies for a variety of diseases, including cancer, autoimmune disorders, and neurological conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#762 in San Diego, CA

#10,578 in California

#45,007 in US

San Diego, CA, United States of America

Epigen Biosciences, Inc.

Forward Citations = 2

6 inventors:

Graham Beaton (6 out of 13 patents)

Chandravadan R Shah (6 out of 36 patents)

Fabio C Tucci (6 out of 20 patents)

4. Satheesh Babu Ravula (6 out of 11 patents)

5. Hiep Luu (4 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Epigen Biosciences, Inc.. Retrieved from https://idiyas.com/company/epigen-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]